Platform Enters Exclusive Negotiations with Prospective Acquirer of Arysta LifeScience
Platform is a global and diversified producer of high-technology specialty chemicals and a provider of technical services. The business involves the formulation of a broad range of solutions-oriented specialty chemicals, which are sold into multiple industries, including automotive, agriculture, animal health, electronics, graphic arts, and offshore oil and gas production and drilling. More information on Platform is available at www.platformspecialtyproducts.com.
This press release contains forward-looking statements, including, but not limited to, the pursuit of separation alternatives, the timing of future communications related to the separation, and the anticipated benefits of the separation of Platform’s businesses. Actual results could differ from those projected due to numerous factors, including, without limitation, Platform's ability to successfully complete the proposed separation; the expected form, structure and timing for completion; adverse effects on the two companies' business operations or financial results; market volatility; legal, tax and regulatory requirements; unanticipated delays and transaction expenses; the impact of the proposed separation on Platform's employees, customers, suppliers and lenders; the ability of the two companies to operate independently following the proposed separation; the diverting of management's attention from Platform's ongoing business operations; and the possibility of more attractive strategic options arising in the future. Additional information concerning these and other factors that could cause actual results to vary is, or will be, included in Platform's periodic and other reports filed with the
Investor Relations Contact:
Vice President, Corporate Treasurer and Investor Relations
Source: Platform Specialty Products Corporation